Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.


Conference Conversations: HIV Pharmacist Perspectives from CROI 2022

February 13-16, 2022; Virtual
Listen to expert insights from Fidelia Bernice, PharmD, and Jennifer Cocohoba, PharmD, as they discuss new data presented at CROI 2022, including key findings on investigational options for PrEP, interactions between hormone therapy and PrEP in transgender individuals, impact of anticholinergic drug effects on older PWH, and medication adherence in PWH.
Fidelia Bernice, PharmD
Jennifer Cocohoba Headshot
Jennifer Cocohoba, PharmD
Released: March 15, 2022

In this episode, Fidelia Bernice, PharmD, and Jennifer Cocohoba, PharmD, share insights on new HIV data from CROI 2022, including:

  • Islatravir tissue and plasma distribution after monthly oral dosing
  • Pharmacokinetics, safety, and acceptability of a tenofovir vaginal ring
  • PrEP and Hormone Therapy in Transgender Individuals
  • Anticholinergic drug effects in older PWH
  • Adherence in PWH

Information on this Educational Activity


Fidelia Bernice, PharmD

Clinical Pharmacy Specialist, Infectious Diseases
Department of Pharmacy
University of Maryland Medical Center
Baltimore, Maryland

Fidelia Bernice, PharmD, has no relevant conflicts of interest to report.
Jennifer Cocohoba, PharmD

Department of Clinical Pharmacy
University of California, San Francisco
Women's HIV Program
University of California San Francisco Medical Center
San Francisco, California

Jennifer Cocohoba, PharmD, has disclosed that she has received funds for research support from ViiV and educational contracts for university fellowship programs from Genentech and Janssen.

Program Medium

This program has been made available online.


Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
Merck & Co., Inc.
ViiV Healthcare

Related Content

Clinical Care Options (CCO) expert analysis of new data from IDWeek and HIV Glasgow 2022, provided by expert HIV faculty

Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD Babafemi Taiwo, MBBS Released: November 30, 2022

Clinical Care Options (CCO) expert analysis of new data from IDWeek and HIV Glasgow 2022, provided by expert HIV faculty

Joseph J. Eron, Jr., MD Karine Lacombe, MD, PhD Released: November 30, 2022

European pioneers discuss the latest data and guideline recommendations for implementing LA ART into practice, from Clinical Care Options (CCO)

Celia Jonsson-Oldenbuettel, MD, PhD
Program Director
person default Tom Stephane De Wit, MD, PhD Eric Florence, MD, PhD Mireia SantaCreu Guerrero, MSN person default Laurence Slama, MD, PhD
Released: November 29, 2022

Dr Colleen Kelley discusses key advances in HIV prevention over the past year, from Clinical Care Options (CCO)

Colleen Kelley, MD, MPH Released: November 29, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings